Escherichia coli endotoxin increases cytosolic free Ca2+ by mobilizing intracellular calcium stores in cultured endothelial cells

Journal of Endotoxin Research

Volumn 3, Issue 2, 1996, Pages 119-127

  Burnier, M ^a,b   Centeno, G ^a  

^a Division of Hypertension   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA (MICROORGANISMS); BOVINAE; ESCHERICHIA COLI;

BACTERIUM LIPOPOLYSACCHARIDE; ESCHERICHIA COLI ENDOTOXIN; VASOPRESSIN;

ANIMAL CELL; ARTICLE; BLOOD VESSEL REACTIVITY; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CALCIUM TRANSPORT; CATTLE; CYTOSOL; DRUG EFFECT; ENDOTHELIUM CELL; ENDOTOXEMIA; GENE EXPRESSION; INOTROPISM; NONHUMAN; PROTEIN SYNTHESIS; VASCULAR RESISTANCE;

EID: 0029952632     PISSN: 09680519     EISSN: None     Source Type: Journal    
DOI: 10.1177/096805199600300205     Document Type: Article

References (48)

1. Abel F.L. Does the heart fail in endotoxin shock? Circ Shock 1990; 30: 5-13.
2. Groenenweld A.B.J., Thijs L.J. Haemodynamic determinants of mortality in human septic shock. Surgery 1986; 99: 140-152.
3. Evequoz D., Waeber B., Corder R., Nussberger J., Gaillard R., Brunner H.R. Markedly reduced blood pressure responsiveness in endotoxemic rats; reversal by neuropeptide Y. Life Sci 1987; 41: 2573-2580.
4. Schaller M.D., Waeber B., Nussberger J., Brunner H.R. Angiotensin II, vasopressin and sympathetic activity in the rat with endotoxemia. Am J Physiol 1985; 249: H1086-H1092.
5. Beasley D. Interleukin 1 and endotoxin activate soluble guanylate cyclase in vascular smooth muscle. Am J Physiol 1990; 259: R38-R44.
6. Beasley D., Cohen R.A., Levinsky N.G. Endotoxin inhibits contraction of vascular smooth muscle in vitro. Am J Physiol 1990; 258: H1187-H1192
7. Julou-Schaeffer G., Gray G.A., Fleming I., Schott C., Parratt J.R., Stoclet J.C. Loss of vascular responsiveness induced by endotoxin involves L-arginine pathway. Am J Physiol 1990; 259: H1038-H1043.
8. McKenna T.M. Prolonged exposure of rat aorta to low levels of endotoxin in vitro results in impaired contractility. Association with vascular cytokine release. J Clin Invest 1990; 86: 160-168.
9. Schneider F., Schott C., Stoclet J.C., Julou-Schaeffer G. L-arginine induces relaxation of small mesenteric arteries from endotoxin-treated rats. Eur J Pharmacol 1992; 211: 269-272.
10. Wakabayashi I., Hatake K., Kakishita E., Nagai K. Diminution of contractile response of the aorta from endotoxin-injected rats. Eur J Pharmacol 1987; 141: 117-122.
11. Knowles R.G., Slater M., Brooks S.L., Moncada S. Anti-inflammatory glucocorticoids inhibit the induction by endotoxin of nitric oxide synthase in the lung, liver, and aorta of the rat. Biochem Biophys Res Commun 1990; 172: 1042-1048.
12. Moncada S., Palmer R.M.J., Higgs E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43: 109-142.
13. Radomski M.W., Palmer R.M., Moncada S. Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc Natl Acad Sci USA 1990; 87: 10043-10047.
14. Rees D.D., Cellek S., Palmer R.M., Moncada S. Dexamethasone prevents the induction by endotoxin of a nitric oxide synthase and the associated effects on vascular tone: an insight into endotoxin shock. Biochem Biophys Res Commun 1990; 173: 541-547.
15. G-methyl-L-arginine, an inhibitor of nitric oxide synthesis. Biochem Biophys Res Commun 1990; 172: 1132-1138.
16. G-methyl-L-arginine inhibits tumour necrosis factor-induced hypotension: implications for the involvement of nitric oxide. Proc Natl Acad Sci USA 1990; 87: 3629-3632.
17. Fleming I., Gray G.A., Julou-Schaeffer G., Parratt J.R., Stoclet J.C. Incubation with endotoxin activates the L-arginine pathway in vascular tissue. Biochem Biophys Res Commun 1990; 171: 562-568.
18. Hollenberg S.M., Cunnion R.E., Zimmerberg J. Nitric oxide synthase inhibition reverses arteriolar hyporesponsiveness to catecholamines in septic rats. Am J Physiol 1993; 264: H660-H663.
19. Schott C.A., Gray G.A., Stoclet J.C. Dependence of endotoxin-induced vascular hyporeactivity on extracellular L-arginine. Br J Pharmacol 1993; 108: 38-43.
20. Stuehr D.J., Kwon N.S., Gross S.S., Thiel B.A., Levi R., Nathan C.F. Synthesis of nitrogen oxide from L-arginine by macrophage cytosol: requirements for inducible and constitutive components. Biochem Biophys Res Commun 1989; 161: 420-426.
21. Burnier M., Waeber B., Aubert J.F., Nussberger J., Brunner H.R. Effects of nonhypotensive endotoxemia in conscious rats: role of prostaglandins. Am J Physiol 1988; 254: H509-H516.
22. Baydoun A.R., Foale R.D., Mann G.E. Bacterial endotoxin rapidly stimulates prolonged endothelium-dependent vasodilatation in the rat isolated perfused heart. Br J Pharmacol 1993; 109: 987-991.
23. 2+ channels in smooth muscle cells. Am J Physiol 1989; 257: C875-C881.
24. Kilboum R., Belloni P. Endothelial cell production of nitrogen oxides in response to interferon gamma in combination with tumour necrosis factor, interleukin-1, or endotoxin. J Natl Cancer Inst 1990; 82: 772-776.
25. Salvemini D., Korbut R., Anggard E., Vane J. Immediate release of a nitric oxide-like factor from bovine aortic endothelial cells by Escherichia coli lipopolysaccharide. Proc Natl Acad Sci USA 1990; 87: 2593-2597.
26. Griffiths M.J.D., Messent M., Evans T.W. The role of nitric oxide in the pulmonary vascular response to endotoxin. Thorax 1993; 48: 467.
27. G-nitro-L-arginine methyl ester and vasopressin in endotoxin-treated pithed rats. Eur J Pharmacol 1992; 224: 63-69.
28. Szabo C., Mitchell J., Thiemermann C., Vane J. Nitric oxide-mediated hyporeactivity to noradrenaline precedes the induction of nitric oxide synthase in endotoxin shock. Br J Pharmacol 1993; 108: 786-792.
29. Thiermerman C., Vane J.R. Inhibition of nitric oxide synthesis reduces the hypotension in the rat in vivo. Eur J Pharmacol 1990; 182: 591-595.
30. Wright C.E., Rees D.D., Moncada S. Protective and pathological role of nitric oxide in endotoxin shock. Cardiovasc Res 1992; 26: 48-57.
31. Booyse F.M., Sedlak B.J., Rafelson Jr M.E. Culture of arterial endothelial cells. Characterization and growth of bovine aortic cells. Thromb Haemost 1975; 34, 825-839.
32. Burnier M., Centeno G., Burki E., Brunner H.R. Confocal microscopy to analyse cytosolic and nuclear calcium in cultured vascular cells. Am J Physiol 1994; 266: C1118-C1127.
33. Curzen N.P., Griffiths M.J.D., Evans T.W. Role of endothelium in modulating the vascular response to sepsis. Clin Sci 1994; 86: 359-374.
34. Adams D.O., Körner D.C. Gene regulation in macrophage development and activation. In: Cruse J.M., Lewis Jr R.E. (Eds) The Year in Immunology, Volume 4 Cellular, Molecular and Clinical Aspects. Basel: Karger, 1988; 159.
35. Dziarski R. Correlation between ribosylation of pertussis toxin substrates and inhibition of peptidoglycan-, muramyldipeptide-and lipopolysaccharide-induced mitogenic stimulation in B lymphocytes. Eur J Immunol 1989; 19: 125-130.
36. Forehand J.R., Pabst M.J., Phillips W.A., Johnston Jr R.B. Lipopolysaccharide priming of human neutrophils for an enhanced respiratory burst. Role of intracellular free calcium. J Clin Invest 1989; 83: 74-83.
37. Vosbeck K., Tobias P.S., Mueller H. et al. Priming of polymorphonuclear granulocytes by lipopolysaccharides and its complexes with lipopolysaccharide-binding protein and high density lipoprotein. J Leukoc Biol 1990; 47: 97-104.
38. Weinstein S.L., Gold M.R., DeFranco A.L. Bacterial lipopolysaccharide stimulates protein tyrosine phosphorylation in macrophages. Proc Natl Acad Sci USA 1991; 88: 4148-4152.
39. Stefanova I., Corcoran M.L., Horak E.M., Wahl L.M., Bolen J.B., Horak I.D. Lipopolysaccharide induces activation of CD14-associated protein tyrosine kinase p53/56lyn. J Biol Chem 1993; 268: 20725-20728.
40. Burnier M., Burki E., Centeno G., Waeber B., Brunner H.R. Effects of endotoxin on angiotensin II receptors synthesis and coupling in rat vascular smooth muscle cells. Circulation 1992; 86 (suppl.4): I-275.
41. Fleming I., Dambacher T., Busse R. Endothelium-derived kinins account for the immediate response of endothelial cells to bacterial lipopolysaccharide. J Cardiovasc Pharmacol 1992; 20 (suppl. 12): S135-S138.
42. 2 activity in human neutrophils. Stimulation by lipopolysaccharide and possible involvement in priming for an enhanced respiratory burst. J Immunol 1993; 151: 4918-4925.
43. Prpic V., Weiel J.E., Somers S.D. et al. Effects of bacterial lipopolysaccharide on the hydrolysis of phosphatidylinositol-4,-5-biphosphate in murine peritoneal macrophages. J Immunol 1987; 139: 526-533.
44. 2+ mobilization in 70T/3 pre-B lymphocytes. J Biol Chem 1985; 260: 9209-9215.
45. 2+ mobilization and nitric oxide biosynthesis in cultured endothelial cells. Circ Res 1994; 75: 659-668.
46. Pugin J., Schürer-Maly C-C., Leturcq D., Moriarty A., Ulevitch R.J., Tobias P.S. Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. Proc Natl Acad Sci USA 1993; 90: 2744-2748.
47. Pugin J., Ulevitch R.J., Tobias P.S. A critical role for monocytes and CD14 in endotoxin-induced endothelial cell activation. J Exp Med 1993; 178: 2193-2200.
48. Williamson J.R., Hansen C.A., Verhoeven A. Mechanism of action of vasopressin as a calcium mobilizing hormone. In: Cowley Jr A.W., Liard J.F., Ausiello D.A. (Eds) Vasopressin: Cellular and Integrative Functions. New York: Raven Press, 1988; 33-43.